Novel blood-based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non-small-cell lung cancer: Results from two multicenter, randomized clinical trials

Lung Cancer
08/06/2020

Yu Y, et al. Clin Transl Med 2020.

NO ABSTRACT